Sun Pharma

M-cap of top seven companies decline by Rs 45,963 cr

The combined market valuation of top seven companies declined by Rs 45,962.77 crore last week with IT majors -- Infosys and TCS -- taking the maximum hit.

M-cap of top seven companies decline by Rs 45,963 cr

Sun Pharma enters into derma segment

The company will co-promote Suncros brand across prescription and consumer channels to drive growth Sun Pharma will focus on dermatology as the fourth engine of growth for its OTC business. As part of this growth strategy, th

Sun Pharma announces divestment of US manufacturing units

Divests two units to Frontida BioPharm

Sun Pharma sells two US-based plants to Frontida BioPharm

Drug major Sun Pharmaceutical Industries has sold two of its US-based manufacturing facilities along with 15 products to Frontida BioPharm Inc for an undisclosed amount.

Sun Pharma sells two US-based plants to Frontida BioPharm

Sun’s problems to linger on for 2-3 quarters: Jefferies

Headwinds plaguing the country's largest drug-maker Sun Pharmaceutical will continue for next two-three quarters owing to pricing pressures and regulatory issues dogging its Halol plant, says a report.

Sun’s problems to linger on for 2-3 quarters: Jefferies

Sun Pharma revenue growth guidance at 8-10 pc for FY’17

Sun Pharma also said that its board has decided to evaluate a proposal for buyback of equity shares and will hold a meeting on June 23 for the purpose.

Sun Pharma revenue growth guidance at 8-10 pc for FY’17

Sun Pharma shares fall 6% on weak sales guidance

Sun Pharmaceutical Industries shares plunged nearly 6 per cent in late morning trade on Tuesday after the pharma company posted a weaker-than expected annual sales outlook as it grappled with increased competition in the Unit

Sun Pharma shares fall 6% on weak sales guidance

Sun Pharma Q4 profit at Rs 1,713.69 cr

Country's largest drug maker Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,713.69 crore for the fourth quarter ended March 31, 2016.

Sun Pharma Q4 profit at Rs 1,713.69 cr

M-cap of top 10 companies swells by Rs 98,598 cr, ITC biggest gainer

Driven by a sharp rally in the stock market last week, the combined market valuation of top- 10 most valued Indian companies soared by a whopping Rs 98,598 crore, with ITC emerging as the biggest mover.

M-cap of top 10 companies swells by Rs 98,598 cr, ITC biggest gainer

Sun Pharma shares surge over 5% on termination of transition pact with Daiichi

Sun Pharma shares rallied after it said that the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.

Sun Pharma shares surge over 5% on termination of transition pact with Daiichi

Sun Pharma launches mobile app for asthma patients

RespiTrack seeks to enable doctors to track treatment progress of their patients and increase compliance to medication

Nine of top 10 bluechip companies lose Rs 47,932 cr in market cap

The combined market valuation of nine of the top 10 most valued Indian companies diminished by Rs 47,932.59 crore last week, with IT major TCS taking the biggest hit.

Nine of top 10 bluechip companies lose Rs 47,932 cr in market cap

ICGEB and Sun Pharma sign agreement to develop botanical drug to treat dengue

ICGEB will provide the technical know-how and pre-clinical expertise and Sun Pharma to develop this drug with appropriate pre-clinical & clinical studies to register it in India and other global markets

Sun Pharma announces positive results of two phase-III CTs of Tildrakizumab

The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in active-comparator etanercept arm

ICMR, MoHFW, Govt. of Madhya Pradesh and Sun Pharma in agreement for Malaria Free India

Partnership to demonstrate malaria elimination in over 1,200 villages of MP's Mandla district by FY21

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement

TRENDING NOW

BUDGET 2019

Related Articles

Switch to Hindi Edition
FinancialExpress_1x1_Imp_Desktop